Helping Daytona Beach patients explore new treatments for high cholesterol and blocked arteries through safe, expertly managed clinical studies.
Cholesterol & Heart Protection Study
We are conducting a research study to learn more about a medication called inclisiran and how it may help people who have heart or blood vessel disease. The goal of this study is to see if inclisiran can reduce the risk of future heart problems, strokes, or issues with blood flow in the legs after certain medical procedures to open blocked arteries.
Inclisiran is already FDA-approved as an injection given just twice a year to help lower “bad” cholesterol (LDL-C). This study will test if it can provide additional benefits for people who have recently had a procedure to restore blood flow in the heart or legs.
Participants will be randomly assigned to receive either inclisiran or a placebo.
Neither you nor the study team will know which one you are receiving during the study.
The first dose will be given shortly after your procedure (or within 2 weeks). After that, doses are given every 6 months.
Everyone in the study will continue to receive their regular medical care.
Study duration: The study will last about 3 to 4 years, depending on when enough information is collected.
Why join? By joining this study, you may help researchers discover new ways to protect people with heart and blood vessel disease from future serious health problems. You will also receive study-related medical care from our experienced team at no cost.
Study Eligibility
Age
Adults 18+
Gender
All genders welcome
Condition
Diagnosed with ASCVD, and undergoing PCI/PVI.
Medical History
Must have had a stent placed in the past 14 days
Location
Daytona Beach, FL
Enrolling Now
Fill out the form below to see if you qualify for our cholesterol & heart protection study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
Study Sponsor
Reimagining medicine to improve and extend lives
Novartis is a global medicines company developing innovative therapies across cardiovascular, immunology, neuroscience, and oncology. Novartis is the sponsor of the abelacimab and inclisiran clinical programs in development at Arrow.
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach is an opportunity to take charge of your health while helping advance medical science — all while under the care of experienced local physicians.
From our blog
Arrow has announced enrollment for a groundbreaking heart protection study evaluating inclisiran for preventing major adverse events from clogged arteries — including heart attack, stroke, and limb-threatening complications.
Read the article →Daytona Cardiology Clinical Trials
This study is testing a medication called inclisiran, which is already FDA-approved to help lower “bad” cholesterol (LDL-C). Researchers want to see if it can also lower the risk of future heart problems, strokes, or circulation issues in the legs after certain artery procedures.
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology. Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required. Any procedures, tests, or study-related care will be covered by the trial sponsor.
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
Each study has specific requirements, such as age range, medical history, and current health status. Our research team will review your information and conduct a screening process to determine if you qualify.
Your feedback is invaluable to us. Please take a moment to share your experience with Arrow Clinical Trials.
